2018
DOI: 10.2174/1570161115666170406105753
|View full text |Cite
|
Sign up to set email alerts
|

Antithrombotic Therapy for Transcatheter Valvular Interventions: A Revisit

Abstract: We will discuss prior experience with MitraClip for antithrombotic use. It is imperative for patients undergoing transcatheter valvular interventions to have optimal antithrombotic therapy that balances between ischaemic and haemorrhagic complications. The appropriate timing, combination, and duration of antithrombotic medications need consensus to weigh between the efficacy, efficiency and adverse effects in patients with transcatheter valvular interventions.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2020
2020
2020
2020

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…Although this rationale might seem insufficient to offset cardiac surgery stroke risk, it may embody the recommendation for anticoagulation, particularly with vitamin K antagonists, which are the only oral anticoagulants indicated in both mitral prosthesis and mitral stenosis 9 . Despite this, no strict peri-and post-MitraClip procedure antithrombotic therapies have been defined so far; distinct protocols are currently being applied 10,11 .…”
Section: Introductionmentioning
confidence: 99%
“…Although this rationale might seem insufficient to offset cardiac surgery stroke risk, it may embody the recommendation for anticoagulation, particularly with vitamin K antagonists, which are the only oral anticoagulants indicated in both mitral prosthesis and mitral stenosis 9 . Despite this, no strict peri-and post-MitraClip procedure antithrombotic therapies have been defined so far; distinct protocols are currently being applied 10,11 .…”
Section: Introductionmentioning
confidence: 99%